Basic Information
Basic information for XIST-214-31aa
Peptide Name XIST-214-31aa
Genome Position chrX:73826295-73826387[-]
Species Human
Peptide Sequence MSPFWVTCCVLFVLFLFCLPLLSLPTSLFSL
Peptide Length 31
Unique No (XIST-203-31aa,XIST-204-31aa-1,XIST-205-31aa,XIST-206-31aa,XIST-211-31aa,XIST-212-31aa,XIST-213-31aa,XIST-215-31aa,XIST-216-31aa,XIST-217-31aa,XIST-218-31aa-1,XIST-219-31aa-1,XIST-220-31aa-2,XIST-221-31aa-1,XIST-222-31aa,XIST-223-31aa-1,XIST-224-31aa,XIST-225-31aa,XIST-226-31aa,XIST-227-31aa,XIST-228-31aa,XIST-230-31aa)
Grand Average of Hydropathicity 1.9323
Relative Molecular Mass 4078.91
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000229807;XIST
Transcript ID/Name ENST00000648091;XIST-214
Transcript Length 2166
Coding Ability 0.6279
DNA Sequence Corresponding to Peptide ATGTCTCCTTTTTGGGTCACATGCTGTGTGCTTTTTGTCCTTTTCTTGTTCTGTCTACCTCTCCTTTCTCTGCCTACCTCTCTTTTCTCTTTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :